Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma

Marina Tshuikina1, Helena Jernberg-Wiklund, Kenneth Nilsson

  • 1Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.

Experimental Hematology
|October 17, 2008
PubMed
Abstract

Insights

Silencing of interferon regulatory factor 8 (IRF8) occurs in most multiple myeloma cell lines and patient cells, often due to DNA methylation. This IRF8 gene silencing may contribute to the malignancy of multiple myeloma.

Area of Science:

  • Hematology
  • Molecular Biology
  • Epigenetics

Background:

  • Multiple myeloma (MM) is an incurable plasma cell malignancy.
  • The interferon regulatory factor (IRF) family's role in MM is not fully understood.
  • Epigenetic modifications, such as DNA methylation, can regulate gene expression in cancer.

Purpose of the Study:

  • To investigate the expression of IRF family members (IRF1-9) in multiple myeloma.
  • To determine the role of DNA methylation in silencing IRF genes, particularly interferon consensus sequence-binding protein (ICSBP/IRF8), in MM.
  • To analyze the association between IRF8 gene silencing and the malignant phenotype of MM.

Main Methods:

  • Quantitative reverse transcriptase polymerase chain reaction and Western blot were used to assess IRF gene expression in 13 MM cell lines and primary MM cells.
  • Pyrosequencing analyzed DNA methylation of the ICSBP/IRF8 promoter.
  • In vitro methylation and 5-aza-2'-deoxycytidine (DAC) treatment were employed to study the effect of methylation on ICSBP/IRF8 expression.

Main Results:

  • ICSBP/IRF8 expression was absent in 8/13 MM cell lines, correlating with promoter hypermethylation.
  • ICSBP/IRF8 was significantly underexpressed in primary MM cells, with methylation present in only one sample.
  • DAC treatment restored ICSBP/IRF8 expression, while in vitro methylation silenced it.

Conclusions:

  • ICSBP/IRF8 gene expression is frequently silenced in multiple myeloma cell lines and primary cells.
  • DNA methylation is a common mechanism for ICSBP/IRF8 silencing in MM cell lines, but other epigenetic mechanisms also contribute.
  • Silencing of ICSBP/IRF8, via DNA methylation or other epigenetic means, may be linked to the malignant characteristics of multiple myeloma.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...